A perspective on polo-like kinase-1 inhibition for the treatment of rhabdomyosarcoma

Research output: Contribution to journalReview article

Authors

  • Ewa Aladowicz
  • Michela Casanova
  • Julia C Chisholm
  • Simone Fulda
  • birgit geoerger
  • Beat Schafer
  • Janet Shipley

Colleges, School and Institutes

External organisations

  • THE INSTITUTE OF CANCER RESEARCH

Details

Original languageEnglish
Article number1271
Number of pages7
JournalFrontiers in Oncology
Volume9
Publication statusPublished - 22 Nov 2019

Keywords

  • polo-like kinase 1, PLK1 inhibitors, rhabdomyosarcomas, combination treatment, microtubule disruptors